Abstracts Archive - Page 348 of 1683 - ATC Abstracts

2020 American Transplant Congress
Association between Pre-Transplant Frailty and Increased Length of Stay after Lung Transplantation
J. Schaenman, N. Ventigan, J. Huang, S. Jaladanki, L. Shih, S. Gee, D. Sayah, S. S. Weigt, A. Ardehali, R. Biniwale, D. Goldwater
David Geffen School of Medicine at UCLA, Los Angeles, CA
*Purpose: Given the growing numbers of older lung transplant candidates, there has been increasing interest in using frailty assessment for risk stratification of transplant candidates.…
2020 American Transplant Congress
Oral versus Intravenous Mycophenolate Mofetil Administration: A Single Center Experience on Incidence of Acute Kidney Injury
P. Chung¹, K. Forrester², S. Ganesh¹
¹Division of Pulmonary Critical and Sleep Medicine, University of Southern California, Los Angeles, CA, ²Department of Clinical Pharmacy, University of Southern California School of Pharmacy, Los Angeles, CA
*Purpose: Mycophenolate mofetil (MMF) is one of the main immunosuppressive medications given in lung transplantation (LTx). It is given orally (PO) or intravenously (IV). In…
2020 American Transplant Congress
Evaluation of SUBA-Itraconazole Use in Lung Transplant Recipients
J. G. Youssef¹, C. Ahmed¹, B. J. Pierce², C. Pham², F. Ye¹, K. Tatum¹, S. Yau¹, A. Goodarzi¹, H. J. Huang¹
¹Department of Medicine, Houston Methodist Hospital, Houston, TX, ²Department of Pharmacy, Houston Methodist Hospital, Houston, TX
*Purpose: Itraconazole (IT) is commonly used after lung transplant for fungal prophylaxis, particularly in those with a history of skin cancer, concern for Histoplasmosis infection,…
2020 American Transplant Congress
Survival Following Simultaneous Liver-Lung versus Liver Alone Transplantation: Results of the US National Experience
J. Purvis, M. C. Mcleod, B. J. Orandi, D. E. Eckhoff, J. E. Locke, R. M. Cannon
Surgery, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Although simultaneous thoracic-abdominal transplants are undoubtedly complex, there is little data to compare the post-transplant survival between lung-liver transplant (LLT) and liver alone recipients.…
2020 American Transplant Congress
Acute Kidney Injury And Chronic Kidney Disease After Lung Transplantation: Incidence And Risk Factors In A Large Single-center Cohort
D. Abdelwahab, R. Marron, Z. Choudhry, I. Lee, J. Wu, J. Brown
Lewis Katz School of Medicine, Temple University, Philadelphia, PA
*Purpose: Chronic kidney disease (CKD) is a common complication after lung transplant. The reported incidence in small studies varies ranges from10-90%. Furthermore, data on risk…
2020 American Transplant Congress
Lung Mucosal Biopsies Deteriorate with Time Post-Transplant: A Molecular Analysis
M. D. Parkes¹, P. Halloran¹, K. Halloran², &. the INTERLUNG Study Group³
¹Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, ²University of Alberta, Edmonton, AB, Canada, ³., ., AB, Canada
*Purpose: Mucosal biopsies from the third airway bifurcation (3BMBs) assessed molecularly can be used to detect rejection (DOI: 10.1111/ajt.15685), and may also provide insights into…
2020 American Transplant Congress
A Quality Improvement Project to Reduce the Risk of Alcohol Relapse after Liver Transplantation by Implementing a High-Risk Alcoholism Relapse Scale
R. V. Tholen¹, E. Bundy²
¹Transplant Nephrology, University of Maryland Medical Center, Baltimore, MD, ²School of Nursing, University of Maryland, Baltimore, Baltimore, MD
*Purpose: Alcoholism is the leading cause of liver-related mortality worldwide. Liver transplantation is considered the only curative treatment for end-stage liver disease. Transplantation will reverse…
2020 American Transplant Congress
Late Onset Primary Graft Dysfunction after Lung Transplantation Correlates with Transplant Arteriosclerosis in a Humanized Mouse Model
M. Franz¹, T. Siemeni¹, A. Knöfel¹, W. Sommer¹, M. Avsar¹, F. Ius¹, I. Tudorache¹, C. Kühn¹, C. S. Falk², G. Warnecke¹, A. Haverich¹
¹Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany, ²IFB-Tx, Hannover Medical School, Hannover, Germany
*Purpose: Primary Graft dysfunction (PGD) is one of the most important causes of early mortality after lung transplantation. We investigated the correlation between the incidence…
2020 American Transplant Congress
Green Channel of Human Organ Transport (GCHOT) Improved the Utilization Rate of Chinese Citizens’ Donated Lungs: A Single-Center Data Analysis
J. Chen, X. Li, C. Hu, F. Liu
Wuxi Lung Transplant Center, Wuxi, China
*Purpose: Lung transplantation in China has been developing for over forty years. Wuxi lung transplant center has the largest lung transplant (LT) volume nationwide. It…
2020 American Transplant Congress
The Effect of UNOS Donor Policy Change on Distance from Recipient Hospital and the Effects on Mortality in Heart Transplantation
P. Kingsford¹, J. P. Li¹, C. J. Lum², A. D. Salimbangon³, G. S. Liu⁴, R. R. Chand⁵, P. Banankhah¹, P. A. Genyk¹, D. Vucicevic¹, K. Pandya¹, J. Rahman¹, M. Fong¹, L. Grazette¹, A. Kiankhooy¹, J. Nattiv¹, S. Hashmi¹, S. B. Nuno¹, J. Pizula¹, D. J. Miklin¹, A. E. Lee¹, K. Yang¹, S. Shah¹, A. S. Vaidya¹, A. M. Wolfson⁶, E. C. DePasquale¹
¹LAC-USC, Los Angeles, CA, ²The Queens Medical Center, Honolulu, HI, ³UCLA Medical Center, Los Angeles, CA, ⁴USC, Los Angeles, CA, ⁵Harbor-UCLA Medical Center, Los Angeles, CA, ⁶University of Arizona Sarver Heart Center, Tucson, AZ
*Purpose: In light of the recent change in the UNOS allocation policy, we sought to evaluate the impact of distance from recipient hospital on mortality.*Methods:…